These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9278207)

  • 1. Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
    Jacqz-Aigrain E; Guillonneau M; Rey E; Macher MA; Montes C; Chiron C; Loirat C
    Br J Clin Pharmacol; 1997 Aug; 44(2):183-5. PubMed ID: 9278207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the individual enantiomers of vigabatrin in neonates with uncontrolled seizures.
    Vauzelle-Kervroëdan F; Rey E; Pons G; d'Athis P; Chiron C; Dulac O; Dumas C; Olive G
    Br J Clin Pharmacol; 1996 Dec; 42(6):779-81. PubMed ID: 8971436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin. Clinical pharmacokinetics.
    Rey E; Pons G; Olive G
    Clin Pharmacokinet; 1992 Oct; 23(4):267-78. PubMed ID: 1395360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin dosing during haemodialysis.
    Bachmann D; Ritz R; Wad N; Haefeli WE
    Seizure; 1996 Sep; 5(3):239-42. PubMed ID: 8902928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.
    Tran A; O'Mahoney T; Rey E; Mai J; Mumford JP; Olive G
    Br J Clin Pharmacol; 1998 Apr; 45(4):409-11. PubMed ID: 9578192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.
    Rey E; Pons G; Richard MO; Vauzelle F; D'Athis P; Chiron C; Dulac O; Beaumont D; Olive G
    Br J Clin Pharmacol; 1990 Aug; 30(2):253-7. PubMed ID: 2206786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction studies between felbamate and vigabatrin.
    Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
    Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.
    Haegele KD; Schechter PJ
    Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of population and standard two-stage pharmacokinetic analyses of vigabatrin data.
    Yu DK; Hutcheson SJ; Wei G; Bhargava VO; Weir SJ
    Biopharm Drug Dispos; 1994 Aug; 15(6):473-84. PubMed ID: 7993985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma vigabatrin enantiomer ratios in adults and children.
    Nagarajan L; Schramm T; Appleton DB; Burke CJ; Eadie MJ
    Clin Exp Neurol; 1993; 30():127-36. PubMed ID: 7712623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic analysis of vigabatrin enantiomers in human serum by precolumn derivatization with o-phthaldialdehyde-N-acetyl-L-cysteine and fluorescence detection.
    Vermeij TA; Edelbroek PM
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):233-8. PubMed ID: 9824236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy.
    Mattson RH; Petroff OA; Rothman D; Behar K
    Acta Neurol Scand Suppl; 1995; 162():27-30. PubMed ID: 7495186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin: new indication. An advance in infantile spasms.
    Prescrire Int; 1998 Apr; 7(34):43-4. PubMed ID: 10183381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin--plasma enantiomer concentrations and clinical effects.
    Sheean G; Schramm T; Anderson DS; Eadie MJ
    Clin Exp Neurol; 1992; 29():107-16. PubMed ID: 1343855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
    Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
    Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
    Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
    Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E; Osborne JP
    J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.